Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itasetron Food Effect and PK Study
NCT02259985Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 1998
- Primary completion
- May 1998
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of itasetron in nausea ((none)) and Vomiting (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration time curve from zero to infinity up to 48 hours, Maximum concentration of drug in plasma up to 48 hours and 1 more. Started Mar 1998; status: completed.
02
Drugs
itasetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT02259985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259985.